★★★★★
“Wonderful health care center. Friendly and really interested in helping you with your health needs.”
Corinne Collins
Peptide therapy
Peptide therapy is one of the most searched, most hyped, and most misunderstood areas of modern wellness. Patients ask about BPC-157, TB-500, Semax, Selank, SS-31, MOTS-c, KPV, GHK-Cu, tesamorelin, and other peptides because they want better recovery, metabolism, energy, focus, skin quality, healthy aging, or resilience. At Simply Health Integrated Medical, that conversation starts with education, safety, regulatory status, evidence, and whether a specific peptide actually fits your goals.
What to expect
Simply Health Integrated Medical helps patients understand symptoms, goals, and options before recommending a care path.
The next step is a consultation request or direct call so the team can determine whether the clinic is a good fit for your needs.
Peptides are short chains of amino acids that can act as signaling molecules in the body. Some are established prescription medications. Others are investigational, compounded, or discussed in wellness settings with much less clinical evidence. That difference matters. The goal is not to chase every trending peptide; it is to understand which pathways are being targeted and whether the benefit-risk profile makes sense for the patient.
BPC-157 is commonly discussed for tendon, ligament, gut, and soft-tissue recovery support, while TB-500 is commonly marketed as a thymosin beta-4-related peptide for repair, mobility, and tissue resilience. The honest version: much of the strongest BPC-157 evidence is still preclinical or early, and published TB-500-specific clinical evidence is not the same as the broader thymosin beta-4 literature. These options deserve careful review, not guaranteed healing claims.
Semax is often searched for focus, cognition, neurologic recovery, and mental performance. Selank is often searched for anxiety, calm, stress resilience, and mood-related support. Some human clinical literature exists, especially outside the United States, but it should be interpreted with caution. A responsible plan reviews sleep, stress load, hormones, medications, neurologic history, and whether these peptides are appropriate or legally available for the patient’s situation.
SS-31, also known as elamipretide, is a mitochondria-targeted peptide studied in specific mitochondrial disorders. MOTS-c is a mitochondria-derived peptide studied for metabolic signaling, exercise biology, insulin sensitivity, and aging-related pathways. Tesamorelin is a growth-hormone-releasing-hormone analog with clinical trial data and approved use in a specific HIV-associated lipodystrophy context. These examples show why context matters: a peptide can be scientifically interesting without being a casual wellness shortcut.
GHK-Cu is commonly discussed for skin quality, collagen signaling, wound-repair biology, and hair or aesthetic support. KPV is a short peptide sequence related to alpha-MSH and is often discussed for inflammatory signaling, gut-barrier questions, and skin or immune-modulation research. These peptides may be interesting for selected goals, but benefit depends on route, formulation, candidacy, and the difference between mechanism studies and proven clinical outcomes.
A good peptide consult should clarify the goal first: pain recovery, joint or tendon support, body composition, appetite and metabolism, cognitive performance, stress resilience, skin quality, hair restoration, immune balance, or healthy aging. From there, the clinic can review medical history, labs, medications, contraindications, pregnancy status, cancer history, autoimmune context, sourcing, monitoring, cost, alternatives, and whether another service should come first.
Peptides should not be purchased blindly online, stacked aggressively, or treated as risk-free because they sound natural. Product quality, dosing, contamination risk, medication interactions, contraindications, and regulatory limits all matter. Peptide therapy should never replace needed medical care, imaging, emergency evaluation, or proven treatment for a diagnosed condition.
If you are curious about BPC-157, TB-500, Semax, Selank, SS-31, MOTS-c, KPV, GHK-Cu, tesamorelin, or another peptide, request a consultation. The next step is to sort the hype from the evidence, identify which options are available and appropriate, and decide whether peptide therapy belongs in your plan at all.
Research & clinical context
These outside resources are included for education and credibility. They do not replace individualized medical advice, but they help explain why evaluation, fit, safety, and realistic expectations matter.
PubMed / Drug Discovery Today
Scientific overview of peptide therapeutics as a category, useful for educational context rather than one-size-fits-all claims.
View source →
PubMed / Sports Medicine
Recent safety-focused review covering approved and unapproved peptide use in musculoskeletal and performance contexts.
View source →
PubMed / HSS Journal
Systematic-review context for BPC-157 interest in orthopedic and sports-medicine settings; evidence remains early and limited.
View source →
PubMed / Annals of the New York Academy of Sciences
Thymosin beta-4 research context relevant to TB-500-related patient questions, with important differences between published Tβ4 research and commercial TB-500 claims.
View source →
PubMed / Zhurnal Nevrologii i Psikhiatrii
Clinical literature often cited around Semax and neurologic recovery; useful for education, not broad cognitive-performance promises.
View source →
PubMed / Zhurnal Nevrologii i Psikhiatrii
Human clinical-literature context for Selank-related anxiety and stress-resilience questions; study setting and generalizability should be reviewed carefully.
View source →
PubMed / Neurology
Randomized clinical-trial context for SS-31 / elamipretide as a mitochondria-targeted peptide in a specific diagnosed condition.
View source →
PubMed / Frontiers in Endocrinology
Review of MOTS-c biology and metabolic-aging research, emphasizing that clinical use remains an emerging area.
View source →
PubMed / International Journal of Molecular Sciences
Review of GHK-Cu mechanisms related to skin repair, collagen signaling, and protective/regenerative biology.
View source →
PubMed / Cells
Mechanistic review relevant to KPV and alpha-MSH-related anti-inflammatory peptide questions; not a treatment claim.
View source →
PubMed / Obesity Research & Clinical Practice
Meta-analysis of randomized trials for tesamorelin in a specific FDA-recognized clinical context, useful for separating approved indications from wellness claims.
View source →
U.S. Food & Drug Administration
Regulatory context reinforcing why peptide- and GLP-1-related prescribing or compounding decisions require caution and clinical oversight.
View source →
Testimonials
A mix of patient testimonials to show a broader range of care experiences.
★★★★★
“Wonderful health care center. Friendly and really interested in helping you with your health needs.”
Corinne Collins
★★★★★
“Simply Health was a very positive experience. From the friendly staff to Dr. Deloney himself, who really puts you at ease and talks to you in an understanding language and a caring tone. With their help, I walked out of there feeling fully equipped to accomplish my goals!”
Sharon Wilding
Next step
A consultation helps the team understand your goals, health history, and whether this service belongs in your care plan. The goal is fit, clarity, and a practical recommendation — not a generic protocol.